VISCONTI, ROBERTA

VISCONTI, ROBERTA  

DIPARTIMENTO DI FARMACIA  

Mostra records
Risultati 1 - 20 di 67 (tempo di esecuzione: 0.042 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients. 1.1 Articolo in rivista 2007 Gigante, B; Bellis, A; Visconti, R; Marino, M; Morisco, Carmine; Trimarco, Valentina; Galasso, Gennaro; Piscione, Federico; DE LUCA, Nicola; Prince, Ja; de Faire, U; Trimarco, Bruno
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, R. M.; Barone, M. V.; Lupoli, Gelsy; Cirafici, A. M.; Carlomagno, F.; Visconti, Roberta; Matoskova, B.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, A.; Santoro, M.
Different mutations of the RET gene cause different human tumoral diseases. 1.1 Articolo in rivista 1999 Santoro, M.; Melillo, R. M.; Carlomagno, F.; Visconti, Roberta; DE VITA, Gabriella; Salvatore, Giuliana; Fusco, A.; Vecchio, Giancarlo
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 1.1 Articolo in rivista 1998 Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 1.1 Articolo in rivista 1998 Chiariello, M; Visconti, R; Carlomagno, Francesca; Melillo, Rosa Marina; Bucci, C; De Franciscis, V; Fox, Gm; Jing, S; Coso, Om; Gutkind, Sj; Fusco, Alfredo; Santoro, M.
Molecular biology of the MEN2 gene 1.1 Articolo in rivista 1998 Santoro, M; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; De Vita, Gabriella; Salvatore, G; Lupoli, G; Fusco, Alfredo; Vecchio, G.
Requirement for proteolysis in spindle assembly checkpoint silencing. 1.1 Articolo in rivista 2010 Visconti, R.; Palazzo, Luca; Grieco, Domenico
New insights on oxidative stress in cancer. 1.1 Articolo in rivista 2009 Visconti, R.; Grieco, Domenico
Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines 1.1 Articolo in rivista 1996 Cerutti, J.; Trapasso, F.; Battaglia, C.; Zhang, L.; Martelli, M. L.; Visconti, R.; Berlingieri, M. T.; Fagin, J. A.; Santoro, Massimo; Fusco, Alfredo
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive. 1.1 Articolo in rivista 2000 Martelli, M. L.; Miano, M. G.; Battaglia, C.; Trapasso, F.; Stella, A.; Iuliano, R.; Visconti, R.; Fagin, J. A.; Santoro, Massimo; Fusco, Alfredo
The Expression of the High-mobility Group Hmgi (y) Proteins Correlates With the Malignant Phenotype of Human Thyroid Neoplasias 1.1 Articolo in rivista 1995 Chiappetta, G.; Bandiera, A.; Berlingieri, M. T.; Visconti, R.; Manfioletti, G.; Battista, S.; Martineztello, F. J.; Santoro, Massimo; Giancotti, V.; Fusco, Alfredo
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 1.1 Articolo in rivista 2001 Salvatore, Domenico; Melillo, Rosa Marina; Monaco, C.; Visconti, R.; Fenzi, G.; Vecchio, G.; Fusco, Alfredo; Santoro, M.
Ret/ptc Oncogene Activation Is An Early Event In Thyroid Carcinogenesis 1.1 Articolo in rivista 1995 Viglietto, G.; Chiappetta, G.; Martineztello, F. J.; Fukunaga, F. H.; Tallini, G.; Rigopoulou, D.; Visconti, R.; Mastro, A.; Santoro, Massimo; Fusco, Alfredo
Akt/PKB promotes survival and hormone-independent proliferation of thyroid cells in the absence of de-differentiated and transforming effects. 1.1 Articolo in rivista 2000 De Vita, Gabriella; Berlingieri, M. T.; Visconti, R.; Castellone, M. D.; Viglietto, G.; Baldassarre, G.; Zannini, Mariastella; Bellacosa, A.; Tsichlis, P. M.; Fusco, A.; Santoro, M.
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 1.1 Articolo in rivista 1997 Cirafici, Am; Salvatore, G; De Vita, G; Carlomagno, Francesca; Dathan, Na; Visonti, R; Melillo, Rosa Marina; Fusco, Alfredo; Santoro, M.; Visconti, Roberta
The platelet derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway. 1.1 Articolo in rivista 2003 Iavarone, C.; Catania, A.; Marinissen, M. J.; Visconti, R.; Acunzo, M.; Tarantino, C.; Carlomagno, Maria Stella; Bruni, Carmelo Bruno; Gutkind, J. S.; Chiariello, M.
TRANSCRIPTIONAL PROFILE OF KI-RAS-INDUCED TRANSFORMATION OF THYROID CELLS. 1.1 Articolo in rivista 2007 Visconti, R.; Federico, Antonella; Coppola, V.; Pentimalli, Francesca; Berlingieri, M. T.; Pallante, P.; Kruhoffer, M.; Orntoft, T. F.; Fusco, Alfredo
The end of mitosis from a phosphatase perspective 1.1 Articolo in rivista 2013 Visconti, Roberta; Pepe, Anna; Rosa Della Monica, ; Grieco, Domenico; Palazzo, Luca
Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas. 1.1 Articolo in rivista 1998 Nigris, F. D.; Visconti, R.; Cerutti, J.; Califano, D.; Mineo, A.; Santoro, Massimo; Santelli, G.; Fusco, Alfredo